COMMUNIQUÉS West-GlobeNewswire

VitalHub Continues to Report Positive Adjusted EBITDA Results and Increased Revenues
23/04/2019
TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and [...]
Tonix Pharmaceuticals Announces Update on the Collaborative Research and Development Agreement (CRADA) with the U.S. Army Medical Materiel Development Activity (USAMMDA)
23/04/2019
The Termination Does Not Affect Tonix’s Finances or the Ongoing RECOVERY Trial of Tonmya® for the Treatment of PTSD NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix [...]
GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending March 31, 2019 and Host Conference Call on May 6, 2019
23/04/2019
LONDON, April 23, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]
Alberta healthcare initiatives recognized for making an impact on patients’ experiences
23/04/2019
CALGARY, Alberta, April 23, 2019 (GLOBE NEWSWIRE) -- The Health Quality Council of Alberta (HQCA) has recognized four initiatives in the province that are making a positive impact on Albertans’ experiences receiving [...]
New Peer Reviewed Data Supports Use of Conformis Customized Knee Implants to Match Anatomic Variability in Patients
23/04/2019
BILLERICA, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint [...]
UPDATE -- AIT Therapeutics to Demonstrate NO Generator and Delivery System at Pediatric Academic Societies Meeting in Baltimore, MD on April 27-30
23/04/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, April 23, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ( [...]
Ossur Hf : Transactions in relation to share buyback program
23/04/2019
Announcement no. 26/2019 23 April 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Inventiva to present new results of its YAP-TEAD oncology program at the AACR Special Conference on The Hippo Pathway
23/04/2019
New study evaluated Inventiva’s YAP-TEAD inhibitors in the treatment of Malignant Pleural Mesothelioma (MPM) Study results show the potential of Inventiva’s compounds to significantly reduce tumor growth, attenuate [...]
Inventiva présentera de nouveaux résultats de son programme YAP-TEAD en oncologie lors de la conférence spéciale de l’AACR dédiée à la voie Hippo
23/04/2019
Une nouvelle étude a évalué les inhibiteurs YAP-TEAD d’Inventiva dans le traitement du mésothéliome pleural malin (MPM) Les résultats de l’étude montrent le potentiel des molécules d’Inventiva pour réduire [...]
Dynamic Digital Radiography Receives FDA Clearance
23/04/2019
WAYNE, N.J., April 23, 2019 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., announces that the transformative technology introduced at RSNA 2018, Dynamic Digital Radiography (DDR), has received 510(k) [...]
Tauriga Sciences Inc. Obtains Legal Analysis/Confirmation Letter from Preeminent CBD Sector Law Firm
23/04/2019
New York, NY, April 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
First Clinical Program Initiated Using Nanoparticles to Treat Retinitis Pigmentosa
23/04/2019
2CTech, Inc. Completes $8 Million Series B Funding to Further Develop Novel Therapeutic Quantum Dots Treatment for Photovoltaic Stimulation of the Neural Retina IRVINE, Calif., April 23, 2019 (GLOBE NEWSWIRE) -- 2Ctech [...]
Cytovance® Biologics Promotes Matt Hamilton to Vice President, Finance
23/04/2019
OKLAHOMA CITY, April 23, 2019 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, has promoted Matt Hamilton to Vice [...]
SonderMind Raises $3 Million in Series A Financing to Advance its Mission of Making Behavioral Health More Accessible, Approachable and Utilized
23/04/2019
Jonathan S. Bush appointed to SonderMind Board of Directors DENVER, April 23, 2019 (GLOBE NEWSWIRE) -- SonderMind Inc., a company dedicated to making behavioral health more accessible, approachable and utilized, today [...]
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Completion of the Merger with OncoMed Pharmaceuticals, Inc.
23/04/2019
Notice of Preliminary Results THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INFORMATION IS NOW CONSIDERED IN THE [...]
Reduction of GN Store Nord’s share capital
23/04/2019
At GN Store Nord’s annual general meeting on March 21, 2019, it was decided to reduce the company’s share capital from nominally DKK 582,736,856 to nominally DKK 569,072,400 by cancelling treasury shares of a nominal [...]
Nova Leap Health Corp. Completes Purchase of Home Care Business in Eastern Canada
23/04/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, April 23, 2019 (GLOBE NEWSWIRE) -- NOVA [...]
Demant A/S: Capital reduction as well as total number of voting rights and capital
23/04/2019
Company announcement no 2019-05 23 April 2019 Completion of capital reduction in Demant A/S As stated in Company announcement no. 2019-04, it was decided at Demant A/S’ ordinary general meeting on 19 March 2019 to [...]
AXIM® Biotechnologies, Inc. Nutraceutical Division Receives Purchase Order for 50,000 Boxes of the Company’s Proprietary CBD-Based Chewing Gum
23/04/2019
NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM ® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today announced that the [...]

Pages